| Elevation Oncology, Inc. ELEV | $11.97M | 4.27 | 2.33M | New | +$11.97M | 1.78 | |
| Keros Therapeutics, Inc. KROS | $95.06M | 3.98 | 1.44M | +35.41% | +$24.86M | 14.13 | |
Beam Therapeutics Inc. BEAM | $70.03M | 2.58 | 2.12M | New | +$70.03M | 10.41 | |
| Vaxcyte, Inc. PCVX | $187.91M | 2.53 | 2.75M | +374.31% | +$148.29M | 27.94 | |
| Nuvalent, Inc. NUVL | $107.9M | 2.23 | 1.44M | +2,390.49% | +$103.57M | 16.04 | |
Tourmaline Bio, Inc. TRML | $10.65M | 1.81 | 465,000 | New | +$10.65M | 1.58 | |
| Xencor, Inc. XNCR | $24.56M | 1.8 | 1.11M | New | +$24.56M | 3.65 | |
Biohaven Pharmaceutical Holding Company Ltd. BHVN | $80.78M | 1.67 | 1.48M | New | +$80.78M | 12.01 | |
Apogee Therapeutics, Inc. APGE | $55.3M | 1.42 | 832,198 | New | +$55.3M | 8.22 | |
Spyre Therapeutics, Inc. SYRE | $17.95M | 1.18 | 473,200 | New | +$17.95M | 2.67 | |
| Merck & Co., Inc. MRK | $10.5M | <0.01 | 79,600 | New | +$10.5M | 1.56 |